Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Valentina Garibotto
With
University Hospital, Geneva
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Oligo- metastatic patient with prostate cancer and bone lesions (up to five metastases) based on scintigraphy and whole-body SPECT/CT (staging or recurrence).
Patient must be able to provide informed consent.
Patient is ≥ 18 years old
You may not be if
Patient with another active malignancy.
Patient is \< 18 years old
Patients with contraindications of MRI procedure (metal implants, cardiac pacemakers, old type of prosthesis)
Patients with severe renal impairment (MDRD \< 30)
Clareo Health | 18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients.
